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Background
Due to a lack of antioxidant enzymes in plasma, plasma
proteins are preferential targets of oxidant injury. Reaction
of chlorinated oxidants (e.g. hypochlorous acid), generated
from activated neutrophils, with plasma albumin gives rise
to formation of an oxidized protein fraction, termed
advanced oxidation protein products (AOPPs). AOPP-
albumin is a potent high-density lipoprotein (HDL) recep-
tor antagonist, blocking HDL association and reverse
cholesterol transport (RCT). However, it is not known
whether structural alterations and/or an increase in nega-
tive charge (through oxidation of positively charged lysine
residues on albumin) are required for high affinity binding
to SR-BI.
Methods and results
T-lymphocytes were incubated with AF 488-TFP-labelled
HDL in the presence of different AOPP-albumin prepara-
tions (albumin oxidized in vitro by the myeloperoxidase
product hypochlorous acid). HDL association to SR-BI
was measured by flow cytometry. Our data show that
already mild oxidation of albumin generates a high affinity
ligand to SR-BI that effectively displaces HDL from the
receptor. Oxidation/decomposition of lysine residues are
required for binding of AOPP-albumin to SR-BI since
masking lysine residues prior to oxidation as well as regen-
eration of lysine oxidation products completely averted
binding. Interestingly, modification of albumin-located
lysine residues with reactive carbonyls only moderately
increased binding affinity of albumin to SR-BI.
Conclusions
Structural alterations induced by lysine oxidation rather
than an increased negative charge determine binding
affinity of AOPP-albumin to SR-BI.
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